Different Chronic Stress Paradigms Converge on Endogenous TDP43 Cleavage and Aggregation

[1]  Xiaolan Liu,et al.  The emerging role of autophagy and mitophagy in tauopathies: From pathogenesis to translational implications in Alzheimer’s disease , 2022, Frontiers in Aging Neuroscience.

[2]  Z. Yue,et al.  Regulation of α-synuclein homeostasis and inflammasome activation by microglial autophagy , 2022, Science advances.

[3]  Chao Gao,et al.  Hyperosmotic-stress-induced liquid-liquid phase separation of ALS-related proteins in the nucleus. , 2022, Cell reports.

[4]  L. Petrucelli,et al.  Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases , 2022, Cell.

[5]  A. Ludolph,et al.  Stress induced TDP-43 mobility loss independent of stress granules , 2022, bioRxiv.

[6]  A. Murzin,et al.  Structure of pathological TDP-43 filaments from ALS with FTLD , 2021, Nature.

[7]  V. Manganelli,et al.  Overexpression of Neuroglobin Promotes Energy Metabolism and Autophagy Induction in Human Neuroblastoma SH-SY5Y Cells , 2021, Cells.

[8]  D. Dickson,et al.  TDP-43 Pathology in Alzheimer’s Disease , 2021, Molecular neurodegeneration.

[9]  C. Shaw,et al.  Cytoplasmic TDP-43 is involved in cell fate during stress recovery , 2021, Human molecular genetics.

[10]  E. Wolvetang,et al.  TDP-43 Mutation Affects Stress Granule Dynamics in Differentiated NSC-34 Motoneuron-Like Cells , 2021, Frontiers in Cell and Developmental Biology.

[11]  V. Manganelli,et al.  Protein Aggregation Landscape in Neurodegenerative Diseases: Clinical Relevance and Future Applications , 2021, International journal of molecular sciences.

[12]  John L. Robinson,et al.  TMEM106B modifies TDP-43 pathology in human ALS brain and cell-based models of TDP-43 proteinopathy , 2021, bioRxiv.

[13]  D. Rincon-Limas,et al.  Molecular, functional, and pathological aspects of TDP-43 fragmentation , 2021, iScience.

[14]  J. Satayavivad,et al.  Prolonged arsenic exposure increases tau phosphorylation in differentiated SH-SY5Y cells: The contribution of GSK3 and ERK1/2. , 2021, Environmental toxicology and pharmacology.

[15]  M. Turner,et al.  Detection and quantification of novel C‐terminal TDP‐43 fragments in ALS‐TDP , 2020, Brain pathology.

[16]  P. van Damme,et al.  TDP-43 proteinopathies: a new wave of neurodegenerative diseases , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

[17]  R. Pappu,et al.  Beyond aggregation: Pathological phase transitions in neurodegenerative disease , 2020, Science.

[18]  A. Gitler,et al.  ALS Genetics: Gains, Losses, and Implications for Future Therapies , 2020, Neuron.

[19]  F. Fornai,et al.  Chronic stress induces formation of stress granules and pathological TDP-43 aggregates in human ALS fibroblasts and iPSC-motoneurons , 2020, Neurobiology of Disease.

[20]  Maxime W. C. Rousseaux,et al.  The role of TDP-43 mislocalization in amyotrophic lateral sclerosis , 2020, Molecular Neurodegeneration.

[21]  Lin Guo,et al.  Stress Induces Dynamic, Cytotoxicity-Antagonizing TDP-43 Nuclear Bodies via Paraspeckle LncRNA NEAT1-Mediated Liquid-Liquid Phase Separation. , 2020, Molecular cell.

[22]  P. Manganotti,et al.  TDP-43 real-time quaking induced conversion reaction optimization and detection of seeding activity in CSF of amyotrophic lateral sclerosis and frontotemporal dementia patients , 2020, Brain communications.

[23]  Ray-Jade Chen,et al.  Induction of Autophagy by Vasicinone Protects Neural Cells from Mitochondrial Dysfunction and Attenuates Paraquat-Mediated Parkinson’s Disease Associated α-Synuclein Levels , 2020, Nutrients.

[24]  J. DeFelipe,et al.  Effect of Phosphorylated Tau on Cortical Pyramidal Neuron Morphology during Hibernation , 2020, Cerebral cortex communications.

[25]  C. Besnard‐Guérin.  Cytoplasmic localization of amyotrophic lateral sclerosis‐related TDP‐43 proteins modulates stress granule formation , 2020, The European journal of neuroscience.

[26]  Nicolas L. Fawzi,et al.  TDP-43 α-helical structure tunes liquid–liquid phase separation and function , 2020, Proceedings of the National Academy of Sciences.

[27]  H. Vanderstichele,et al.  Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays , 2020, Translational Neurodegeneration.

[28]  S. Jha,et al.  Early metastable assembly during the stress-induced formation of worm-like amyloid fibrils of nucleic acid binding domains of TDP-43. , 2020, Biochemistry.

[29]  M. Hasegawa,et al.  The basis of clinicopathological heterogeneity in TDP-43 proteinopathy , 2019, Acta Neuropathologica.

[30]  Lin Guo,et al.  Cytoplasmic TDP-43 De-mixing Independent of Stress Granules Drives Inhibition of Nuclear Import, Loss of Nuclear TDP-43, and Cell Death , 2019, Neuron.

[31]  A. Walker,et al.  The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD , 2019, Front. Neurosci..

[32]  Ting Zhao,et al.  Caspase-4 mediates cytoplasmic accumulation of TDP-43 in the primate brains , 2019, Acta Neuropathologica.

[33]  R. Wickner,et al.  Yeast Prions Compared to Functional Prions and Amyloids. , 2018, Journal of molecular biology.

[34]  S. Rossi,et al.  Differential toxicity of TAR DNA‐binding protein 43 isoforms depends on their submitochondrial localization in neuronal cells , 2018, Journal of neurochemistry.

[35]  C. Soto,et al.  Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases , 2018, Nature Neuroscience.

[36]  Luwen Wang,et al.  Pathomechanisms of TDP‐43 in neurodegeneration , 2018, Journal of neurochemistry.

[37]  I. Zerr,et al.  Molecular and Clinical Aspects of Protein Aggregation Assays in Neurodegenerative Diseases , 2018, Molecular Neurobiology.

[38]  I. Zerr,et al.  Applications of the real-time quaking-induced conversion assay in diagnosis, prion strain-typing, drug pre-screening and other amyloidopathies , 2017, Expert review of molecular diagnostics.

[39]  H. Misawa,et al.  Formation and spreading of TDP-43 aggregates in cultured neuronal and glial cells demonstrated by time-lapse imaging , 2017, PloS one.

[40]  N. Brandon,et al.  Truncation of the TAR DNA-binding protein 43 is not a prerequisite for cytoplasmic relocalization, and is suppressed by caspase inhibition and by introduction of the A90V sequence variant , 2017, PloS one.

[41]  A. Hochschild,et al.  A bacterial global regulator forms a prion , 2017, Science.

[42]  F. Santilli,et al.  Morphine Withdrawal Modifies Prion Protein Expression in Rat Hippocampus , 2017, PloS one.

[43]  D. Otzen,et al.  ThT 101: a primer on the use of thioflavin T to investigate amyloid formation , 2017, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[44]  J. Alonso,et al.  Hyperosmotic Stress Induces Tau Proteolysis by Caspase‐3 Activation in SH‐SY5Y Cells , 2016, Journal of cellular biochemistry.

[45]  F. Iacovelli,et al.  Structural insights into the multi-determinant aggregation of TDP-43 in motor neuron-like cells , 2016, Neurobiology of Disease.

[46]  Nicolas L. Fawzi,et al.  ALS Mutations Disrupt Phase Separation Mediated by α-Helical Structure in the TDP-43 Low-Complexity C-Terminal Domain. , 2016, Structure.

[47]  Gregory A. Newby,et al.  Luminidependens (LD) is an Arabidopsis protein with prion behavior , 2016, Proceedings of the National Academy of Sciences.

[48]  Brian D. Slaughter,et al.  Amyloidogenic Oligomerization Transforms Drosophila Orb2 from a Translation Repressor to an Activator , 2015, Cell.

[49]  Moe Yokoshi,et al.  The cleavage pattern of TDP-43 determines its rate of clearance and cytotoxicity , 2015, Nature Communications.

[50]  I. Macreadie,et al.  Pretreatment of chemically-synthesized Aβ42 affects its biological activity in yeast , 2014, Prion.

[51]  P. Zou,et al.  Serum deprivation elevates the levels of microvesicles with different size distributions and selectively enriched proteins in human myeloma cells in vitro , 2013, Acta Pharmacologica Sinica.

[52]  Thomas Arendt,et al.  Neuronal plasticity in hibernation and the proposed role of the microtubule-associated protein tau as a "master switch" regulating synaptic gain in neuronal networks. , 2013, American journal of physiology. Regulatory, integrative and comparative physiology.

[53]  D. Mann,et al.  Prion-like properties of pathological TDP-43 aggregates from diseased brains. , 2013, Cell reports.

[54]  K. Wada,et al.  TDP‐43 associates with stalled ribosomes and contributes to cell survival during cellular stress , 2013, Journal of neurochemistry.

[55]  Ewout J. N. Groen,et al.  Protein aggregation in amyotrophic lateral sclerosis , 2013, Acta Neuropathologica.

[56]  D. Mann,et al.  Molecular analysis and biochemical classification of TDP-43 proteinopathy. , 2012, Brain : a journal of neurology.

[57]  R. Sabaté,et al.  Thioflavin-S staining coupled to flow cytometry. A screening tool to detect in vivo protein aggregation. , 2012, Molecular bioSystems.

[58]  V. Manganelli,et al.  Trafficking of PrPc to mitochondrial raft-like microdomains during cell apoptosis , 2012, Prion.

[59]  P. Crouch,et al.  Endogenous TDP-43 localized to stress granules can subsequently form protein aggregates , 2012, Neurochemistry International.

[60]  T. Saido,et al.  A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology , 2012, Nature Communications.

[61]  P. Matarrese,et al.  Recruitment of cellular prion protein to mitochondrial raft-like microdomains contributes to apoptosis execution , 2011, Molecular biology of the cell.

[62]  C. Masters,et al.  C-Jun N-terminal kinase controls TDP-43 accumulation in stress granules induced by oxidative stress , 2011, Molecular Neurodegeneration.

[63]  Jernej Ule,et al.  TDP‐43 regulates its mRNA levels through a negative feedback loop , 2011, The EMBO journal.

[64]  D. M. Mengual Gómez,et al.  Effects of Fetal Bovine Serum deprivation in cell cultures on the production of Anticarsia gemmatalis Multinucleopolyhedrovirus , 2010, BMC biotechnology.

[65]  M. Biancalana,et al.  Molecular mechanism of Thioflavin-T binding to amyloid fibrils. , 2010, Biochimica et biophysica acta.

[66]  M. Piccinini,et al.  TDP‐43 Redistribution is an Early Event in Sporadic Amyotrophic Lateral Sclerosis , 2010, Brain pathology.

[67]  A. Echaniz-Laguna,et al.  TDP43-Positive Intraneuronal Inclusions in a Patient with Motor Neuron Disease and Parkinson’s Disease , 2010, Neurodegenerative Diseases.

[68]  Eric R. Kandel,et al.  Aplysia CPEB Can Form Prion-like Multimers in Sensory Neurons that Contribute to Long-Term Facilitation , 2010, Cell.

[69]  E. Buratti,et al.  TDP‐43 is recruited to stress granules in conditions of oxidative insult , 2009, Journal of neurochemistry.

[70]  John Q Trojanowski,et al.  Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis. , 2009, Human molecular genetics.

[71]  L. Petrucelli,et al.  Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity , 2009, Proceedings of the National Academy of Sciences.

[72]  J. Trojanowski,et al.  Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies , 2009, Acta Neuropathologica.

[73]  M. Morita,et al.  Phosphorylated TDP‐43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis , 2008, Annals of neurology.

[74]  J. Trojanowski,et al.  Pathological TDP‐43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations , 2007, Annals of neurology.

[75]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[76]  John L. Robinson,et al.  TDP-43 skeins show properties of amyloid in a subset of ALS cases , 2012, Acta Neuropathologica.